Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Compugen Ltd. (CGEN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.8700+0.1700 (+10.00%)
At close: 04:00PM EDT
1.9300 +0.06 (+3.21%)
After hours: 07:17PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.9400
Open1.9800
Bid1.8500 x 800
Ask1.9300 x 3200
Day's Range1.8000 - 2.0500
52 Week Range1.6600 - 9.2000
Volume1,317,843
Avg. Volume916,931
Market Cap157.161M
Beta (5Y Monthly)2.39
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • PR Newswire

    Compugen Reports First Quarter 2022 Results

    Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today financial results for the first quarter ended March 31, 2022 and provided a corporate update on key events since the start of 2022.

  • PR Newswire

    Compugen Announces CFO Departure

    Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that Mr. Ari Krashin, Chief Financial Officer and Chief Operating Officer of Compugen Ltd. (the "Company"), notified the Company of his wish to depart from his position at the Company to pursue other interests. Mr. Krashin will leave in August 2022 and, until his departure, he will continue to support the Company in his current roles. The departure is not r

  • PR Newswire

    Compugen to Release First Quarter 2022 on Monday, May 16, 2022

    Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, announced today that the Company will release its first quarter 2022 financial results on Monday, May 16, 2022, before the U.S. financial markets open. Management will not host a conference call to accompany this release.

Advertisement
Advertisement